Dr Sharman's latest blog highlights a less than 4 minute video showing how Dr Carl June of the University of Pennsylvania used CAR-T technology to successfully cure a child's otherwise incurable leukaemia.
CAR-T technology uses a modified HIV virus to activate T-cells to multiply in the body and kill leukaemia cells. It has been used to successfully cure CLL in a couple of patients, but needs considerably more development to make it affordable and widely applicable, as currently it involves using the patient's own T-lymphocytes to overcome rejection. It also leaves CLL patients with no B-lymphocytes, so they need IVIG transfusions thereafter to boost their immunity.
Dr Sharman's blog on the video:
cll-nhl.com/2013/06/enginee...
and on CAR-T-Cell technology:
cll-nhl.com/2012/09/genetic...
Neil
Encouraging phase 1 trial results for GLPG5201, a CAR T-cell therapy
More CAR-T: Looking Back to Go Forward in CAR-T Cell Therapy in R/R CLL 
